21 May 2013
Keywords: roche, saquinavir, safe, hiv-infected, patients, hoffmann-la, new
Article | 24 April 1995
Hoffmann-La Roche's new antiviral saquinavir, an orally-active,
selective inhibitor of HIV proteinase, is safe and active in the
treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 1995
20 May 2013
© 2013 thepharmaletter.com